|CASE REPORT - INFECTION
|Year : 2019 | Volume
| Issue : 2 | Page : 459-464
Cervicofacial infections caused by Staphylococcus aureus
Carlos Lazarte, Leonel Paladino, Luciana Mollo, Romina Katra, Brusca Marķa Isabel, Sebastian Ariel Puia
Chair of Surgery and Traumatology Bucomaxilofacial I, Faculty of Dentistry, University of Buenos Aires, Andress: Marcelo Torcuato de Alvear 2142. Buenos Aires, Argentina
|Date of Web Publication||11-Dec-2019|
Brusca Marķa Isabel
Chair of Surgery and Traumatology Buco Maxilo Facial I, Faculty of Dentistry, University of Buenos Aires. Buenos Aires
Staphylococcus aureus (S. aureus) is an opportunistic pathogen that causes a wide range of diseases. Dissemination of perioral infections is a common problem in the field of oral and maxillofacial surgery. The aim of the study was to evaluate S. aureus carriage in the oral cavity and its dissemination to different cervicofacial regions. Clinical case 1 is a patient with a systemic history of type I diabetes which led to foot amputation one year previou sly, who presented alteration of ocular motility and the culture showed Grampositive cocci compatible with S. aureus. The patient was discharged after eight days of antibiotic therapy and drainage. Clinical case 2 was a young female without any comorbidities who had never been hospitalized before or even exposed to the hospital environment. The presence of lesions compatible with necrotizing fasciitis (NF) in the lower lip mucosal region, rapid evolution of the infection to deep planes, and evolution of the clinical picture alerted health-care providers to the need for prompt care. Clinical case 3 was an immunosuppressed patient with cellulitis which is a bacterial infection of the skin and soft tissues that occurs when the physical barrier of the skin and soft tissues, the immune system, and/or the circulatory system are affected. S. aureus is an opportunistic pathogen which causes a wide range of diseases. It inhabits the oral cavity, from where it can spread to distant cervicofacial regions. This is why it is important for health-care professionals to be aware of this niche in case of dissemination in order to provide prompt diagnosis and appropriate treatment.
Keywords: Dissemination, opportunistic microorganisms, Staphylococcus aureus
|How to cite this article:|
Lazarte C, Paladino L, Mollo L, Katra R, Isabel BM, Puia SA. Cervicofacial infections caused by Staphylococcus aureus. Ann Maxillofac Surg 2019;9:459-64
|How to cite this URL:|
Lazarte C, Paladino L, Mollo L, Katra R, Isabel BM, Puia SA. Cervicofacial infections caused by Staphylococcus aureus. Ann Maxillofac Surg [serial online] 2019 [cited 2021 Aug 5];9:459-64. Available from: https://www.amsjournal.com/text.asp?2019/9/2/459/272591
| Introduction|| |
Staphylococcus aureus is an opportunistic pathogen that causes a wide range of diseases. Dissemination of perioral infections is a common problem in the field of oral and maxillofacial surgery. Recent research has established that once phagocytosed by neutrophils and macrophages, a certain percentage of S. aureus is able to survive within those phagocytes, which may even contribute to dissemination of the pathogen. S. aureus also induces its uptake by nonphagocytic cells, and the ensuing intracellular cytotoxicity is suggested to lead to tissue destruction, while bacterial persistence within cells is thought to lead to evasion from the immune response leading to chronic infections.
Infections caused by methicillin-resistant S. aureus (MRSA) have been associated to worsened posttreatment outcomes and higher costs for health-care systems than susceptible infections (methicillin-susceptible S. aureus [MSSA]). Klein et al. found that although MRSA infections had previously been associated with higher hospitalization costs, the costs associated with MSSA-related infections have caught up or even exceeded them.
Among the pathologies that may be caused by MSSA, endophthalmitis is a rare, serious inflammation of intraocular tissues and fluids, which affects the anterior and posterior ocular segments and adjacent sclera. Endophthalmitis of any kind, whether exogenous or endogenous, may lead to a significant reduction in visual acuity and in the worst of cases cause loss of the affected eye. Exogenous endophthalmitis is caused by microbial pathogens entering the eye after surgery or trauma or infiltrating through the surface. Microbial keratitis-induced endophthalmitis is a disease that puts vision at risk, often presenting the worst possible visual outcome.,
Literature reports a wide range of prevalence rates, probably due to the lack of a common definition for microbial keratitis, which is even more lacking for microbial keratitis-induced endophthalmitis. Inconsistencies in routine smear tests for initially mild cases of keratitis which later turn into endophthalmitis may further obscure the accurate estimation of microbial association and detection rates. We present herein three clinical cases to illustrate this.
Jagadish Chandra showed that Staphylococcus species are the most common pathogens in orofacial infections originating from odontogenic infections. Cuesta et al. identified MRSA in 7.3% of periodontal pockets and 7.3% of oral cavities.
Community-acquired MRSA (CA-MRSA) infections have also been reported to occur in immunocompetent individuals without risk factors traditionally associated to CA-MRSA HEA-MRSA.
Of course, it has also been reported to be increased in immunosuppressed individuals, with Staphylococcus being one of the major hospital-acquired pathogens with risk of mortality. It is one of the most common bacteria in the skin and can, therefore, cause dermatitis or disseminate from a wound.
S. aureus is a colonizer present in approximately 30%–50% of skin and mucosa  and is capable of incorporating genetic material from other microorganisms, thereby increasing its virulence and resistance to antimicrobial agents.
The aim of the study was to evaluate S. aureus carriage in the oral cavity and its dissemination to different cervicofacial regions.
| Clinical Cases|| |
Clinical case 1
Clinical case 1 is a 29-year-old male patient with a systemic history of type I diabetes which led to foot amputation 1 year previously, who visited the emergency room at Eva Perón Municipal Hospital in Merlo, Buenos Aires Province, Argentina. He presented with a right orbital abscess [Figure 1]a.
|Figure 1: (a) Case 1, Right orbital abscess. (b) Case 2, Increase in volume in the labial, submental, and submaxillary regions. Presence of crusts in lower labial half-mucous. (c) Case 3, Volume increase of the right submaxillary region, with purulent secretion|
Click here to view
The patient presented alteration of ocular motility (unable to open). Routine blood tests were performed, finding high blood sugar and ketoacidosis. Medical consultation was requested with clinical medicine, ophthalmology, and maxillofacial surgery. It was decided to hospitalize the patient [Figure 2]a.
|Figure 2: (a) Case 1, Axial computed tomography of the craniofacial massif. Purulent collection is observed. (b) Case 2, Ulcer in mucosa of the lower lip with multiple foci of tissue necrosis. (c) Case 3, Favorable postoperative evolution|
Click here to view
The maxillofacial surgery service requested a computer tomography (CT) scan of the head and performed drainage from which a sample was taken for culture [Figure 3]a. The Department of Infectious Diseases prescribed a regimen of amoxicillin plus sulbactam 1.5 mg plus clindamycin 600 mg every 6 h. The culture showed Gram-positive cocci compatible with S. aureus.
|Figure 3: (a) Case 1, After the drainage surgery, some laminar drains are placed (b) Case 2, Computed axial tomography of the craniofacial massif. Hypodense image of diffuse contours in the submental and submaxillary regions|
Click here to view
The patient was discharged after eight days. After discharge from the hospital, he was afebrile and hemodynamically stable and therefore continued with follow-up at maxillofacial, clinical medicine, and Infectious Diseases outpatient offices [Figure 4]a.
|Figure 4: (a) Case 1, Favorable postoperative evolution. (b) Case 2, Computed axial tomography of the craniofacial massif. Hypodense image of diffuse contours in the submental and submaxillary regions|
Click here to view
Clinical case 2
Clinical case 2 is a 31-year-old female patient with no systemic history, who visited the emergency room at Eva Perón Municipal Hospital in Merlo, Buenos Aires Province, Argentina. She presented with fever, edema, erythema and pain in the mandible of five days duration.
Cervicofacial examination showed a diffuse induration in the submental region with increase in volume [Figure 1]b. Lower labial mucosa presented a 2 cm × 1.5 cm ulcerated lesion with erythematous borders, indurated and painful [Figure 2]b. It was decided to hospitalize the patient under diagnosis of presumptive NF.
Craniofacial scan showed a small hypodense area with diffuse contours and the presence of multiple nodal formations in submaxillary and submental regions, with a tendency to being grouped, in nonadenomegaly range [Figure 3]b and [Figure 4]b.
Ultrasound was used to explore left hemiface, submaxillary region and at the level of the mandibular angle. It identified an increase in the thickness of subcutaneous cellular tissue associated with an increase in echogenicity of fatty planes and some enlargement of nodes as well as a small mass 9 mm × 5 mm located at the point of the left mandibular angle.
A sample was taken for culture and the patient was indicated for emergent drainage of the submental region [Figure 5] and [Figure 6].
Due to suspected sepsis by S. aureus and Streptococcus spp., antibiotic coverage was indicated with clindamycin 600 mg and vancomycin 1 g every 12 h.
Soft-tissue culture indicated clindamycin- and erythromycin- sensitive, oxacillin-resistant S. aureus. Prognosis for the patient was favorable [Figure 7], [Figure 8], [Figure 9].
|Figure 8: Case 2, Favorable postoperative evolution of the inferior labial semi-mucosa|
Click here to view
|Figure 9: Case 2, Favorable postoperative evolution of the mucosa inferior labial|
Click here to view
Clinical case 3
Clinical case 3 is a 69-year-old male patient with a systemic history of tuberculosis, colon cancer, colostomy, and peritonitis [Figure 1]c. He visited the emergency room at Eva Perón Municipal Hospital in Merlo, Buenos Aires Province, Argentina. He presented with cervical cellulitis on the right side of 14 days duration, signs of dehydration, and hypotension. He reported dysphagia and weight loss. Cervicofacial examination showed an increase in volume in the right submaxillary region that was diffusely swollen and painful with seropurulent discharge. The patient also had trismus. Consultation was held with maxillofacial surgery, clinical medicine, and nutrition. CT scan of the head and neck was requested. Drainage was performed after taking a sample for culture. The patient was hospitalized. Amoxicillin plus sulbactam 1.5 every 6 h was indicated. Soft-tissue culture results indicated S. aureus. When the patient was discharged, he was afebrile and hemodynamically stable and tolerated food by mouth, and colostomy was permeable. Follow-up was performed at maxillofacial, clinical medicine, Infectious Diseases, and nutrition outpatient offices [Figure 2]c.
| Discussion|| |
S. aureus causes a wide variety of infections ranging from minor skin infections to infections of postoperative wounds. The ability of S. aureus to adapt to antibiotics led to the emergence of MRSA in the 1960s. The cause of its resistance to methicillin and all other beta-lactam antibiotics is the mecA gene, which is located on a mobile genetic element: the staphylococcal cassette chromosome mec (SCCmec). There are seven main variants of SCCmec: types I to VII. The first MRSA clones were associated with hospital-acquired infections (HA-MRSA). However, as from the late 1990s, CA-MRSA clones emerged worldwide. S. aureus compared to HA-MRSA and CA-MRSA is often associated with the presence of the toxin Panton–Valentine leukocidin. However, in recent years, the distinction between HA-MRSA and CA-MRSA has begun to disappear, and CA-MRSA is now endemic in many hospitals. This is a matter of concern to health-care professionals around the world, who endeavor to find new therapeutic strategies for patients who do not respond to the usual medication.,
S. aureus is an opportunistic bacterium able to colonize the skin and mucosal membranes in humans and different animal species. Sepsis leads to death in patients with critical diseases. One of the main pathogens responsible for hospital-acquired sepsis is S. aureus. The different responses of patients according to their immune status suggest that immune status is an important clinical indicator which should be taken into account in the treatment of septic patients as well as in the development of new immunomodulating therapies.,
S. aureus is the most frequent pathogen in serious skin and soft-tissue infections, including toxic shock syndrome, myonecrosis/gas gangrene, and NF. Intensive care, control of the source of infection, and broad-spectrum antimicrobial agents are required to treat the initial phase of the disease. Increasing attention is being given to the usefulness of rapid diagnostic tests to help in selecting and reducing the antimicrobial agents for these pathologies. In addition, clinical prediction patterns have proven promising to help predict which patients do not require antimicrobial agents against MRSA. Immune status has been shown to be important in clinical outcomes of some, though not all types of serious infections. The debate regarding the benefits of intravenous immunoglobulin continues in recent literature.,
Long-term mortality following bacteremia by S. aureus is very high. The risk factors associated to long-term mortality were similar to those found for short-term mortality. To improve long-term survival, patients should undergo screening for comorbidity factors associated with S. aureus bacteremia.
Community-acquired S. aureus bacteremia is a serious infection with harmful clinical effects. Chronic diseases are some of the main risk and prognosis factors for this infection. The prevalence of diabetes and heart failure is increasing rapidly worldwide; nevertheless, there is little available information to specifically elucidate the influence of these chronic conditions on the risk and outcome of community-acquired S. aureus bacteremia.
It is with the aim of increasing current knowledge that we wish to record the clinical cases presented herein.
S. aureus bacteremia causes 20%–40% mortality within 30 days of acquisition in developed countries. Diabetes mellitus is associated to considerable morbidity–mortality. The mortality rate is, therefore, higher in patients with both pathologies than in patients without diabetes. The underlying disease, in turn, favors dissemination, for example, to the ocular zone. S. aureus is one of the main pathogenic agents in ocular infections including conjunctivitis, keratitis, and endophthalmitis., It can infect lachrymal duct, eyelid, conjunctiva, cornea, anterior and posterior chambers, and vitreous chamber. Of these infections, those involving the cornea (keratitis) or internal eye chambers (endophthalmitis) are the most threatening due to their potential for causing loss of visual acuity or even blindness.,
S. aureus can also cause NF, a rare infection of the skin and soft tissue involving a rapidly progressive necrosis of surface fascia. If not treated in time, it may cause morbidity and rapid mortality of up to 73%. It is usually caused by inoculation of bacteria in the skin by direct attack or hematogenous dissemination. Beta-hemolytic streptococci (Streptococcus pyogenes) are usually associated to NF. Although it is considered rare, S. aureus is an emerging etiology for NF due to the increasing incidence of CA-MRSA. As in the clinical cases described herein, treatment is usually surgical with exploration and tissue debridement plus antibiotic therapy. In clinical case 2, we presented a young female patient without risk factors who had not been hospitalized or had any prior exposure to a hospital environment. The presence of lesions compatible with NF in the lower lip mucosal region, rapid evolution of the infection to deep planes, and evolution of the clinical picture alerted health-care providers to the need for prompt care.
Clinical case 3 was an immunosuppressed patient with cellulitis, which is a bacterial infection of the skin and soft tissues that occurs when the physical barrier of the skin and soft tissues, the immune system, and/or the circulatory system is affected. Patients with cancer who receive chemotherapy and/or radiotherapy are prone to many changes such as immunosuppression, imbalance of the microbiome, hyposalivation, and local tissue damage.
It should be noted that recent research has established that once phagocyted by neutrophils and macrophages, a certain percentage of S. aureus is able to survive within those phagocytes, which may even contribute to dissemination of the pathogen. S. aureus induces its uptake by nonphagocytic cells, and the ensuing intracellular toxicity is suggested to lead to tissue destruction, while bacterial persistence within cells is thought to lead to evasion of the immune response and chronicity of the infections.
| Conclusion|| |
S. aureus is an opportunistic pathogen which causes a wide range of diseases. It inhabits the oral cavity, from which it can spread to distant cervicofacial regions. This is why it is important for health-care professionals to be aware of this niche in case of dissemination in order to provide prompt diagnosis and appropriate treatment.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Horn J, Stelzner K, Rudel T, Fraunholz M. Inside job: Staphylococcus aureus
host-pathogen interactions. Int J Med Microbiol 2018;308:607-24.
Klein EY, Jiang W, Mojica N, Tseng KK, McNeill R, Cosgrove SE, et al.
National costs associated with methicillin-susceptible and methicillin-resistant Staphylococcus aureus
hospitalizations in the United States, 2010-2014. Clin Infect Dis 2019;68:22-8.
Otri AM, Fares U, Al-Aqaba MA, Miri A, Faraj LA, Said DG, et al.
Profile of sight-threatening infectious keratitis: A prospective study. Acta Ophthalmol 2013;91:643-51.
Henry CR, Flynn HW Jr., Miller D, Forster RK, Alfonso EC. Infectious keratitis progressing to endophthalmitis: A 15-year study of microbiology, associated factors, and clinical outcomes. Ophthalmology 2012;119:2443-9.
Zapp D, Loos D, Feucht N, Khoramnia R, Tandogan T, Reznicek L, et al.
Microbial keratitis-induced endophthalmitis: Incidence, symptoms, therapy, visual prognosis and outcomes. BMC Ophthalmol 2018;18:112.
Jagadish Chandra H, Sripathi Rao BH, Muhammed Manzoor AP, Arun AB. Characterization and antibiotic sensitivity profile of bacteria in orofacial abscesses of odontogenic origin. J Maxillofac Oral Surg 2017;16:445-52.
Cuesta AI, Jewtuchowicz V, Brusca MI, Nastri ML, Rosa AC. Prevalence of Staphylococcus
spp and Candida
spp in the oral cavity and periodontal pockets of periodontal disease patients. Acta Odontol Latinoam 2010;23:20-6.
Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al.
Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus
infections in adults and children. Clin Infect Dis 2011;52:e18-55.
Tamer F, Yuksel ME, Sarifakioglu E, Karabag Y. Staphylococcus aureus
is the most common bacterial agent of the skin flora of patients with seborrheic dermatitis. Dermatol Pract Concept 2018;8:80-4.
Chatterjee SS, Otto M. Improved understanding of factors driving methicillin-resistant Staphylococcus aureus
epidemic waves. Clin Epidemiol 2013;5:205-17.
Lowy FD. Antimicrobial resistance: The example of Staphylococcus aureus
. J Clin Invest 2003;111:1265-73.
Deurenberg RH, Stobberingh EE. The evolution of Staphylococcus aureus
. Infect Genet Evol 2008;8:747-63.
Holubar M, Meng L, Deresinski S. Bacteremia due to methicillin-resistant Staphylococcus aureus
: New therapeutic approaches. Infect Dis Clin North Am 2016;30:491-507.
Banniettis N, Beekmann SE, Polgreen PM, Kaushik S, Kohlhoff S, Gilbert D, et al.
Management practices for methicillin-resistant Staphylococcus aureus
bacteremia by adult infectious diseases physicians. Open Forum Infect Dis 2018;5:ofy093.
Greenberg JA, Hrusch CL, Jaffery MR, David MZ, Daum RS, Hall JB, et al.
Distinct T-helper cell responses to Staphylococcus aureus
bacteremia reflect immunologic comorbidities and correlate with mortality. Crit Care 2018;22:107.
Strauß L, Stegger M, Akpaka PE, Alabi A, Breurec S, Coombs G, et al.
Origin, evolution, and global transmission of community-acquired Staphylococcus aureus
ST8. Proc Natl Acad Sci U S A 2017;114:E10596-604.
Burnham JP, Kollef MH. Treatment of severe skin and soft tissue infections: A review. Curr Opin Infect Dis 2018;31:113-9.
Bouvet C, Gjoni S, Zenelaj B, Lipsky BA, Hakko E, Uçkay I. Staphylococcus aureus
soft tissue infection may increase the risk of subsequent staphylococcal soft tissue infections. Int J Infect Dis 2017;60:44-8.
Gotland N, Uhre ML, Mejer N, Skov R, Petersen A, Larsen AR, et al.
Long-term mortality and causes of death associated with Staphylococcus aureus
bacteremia. A matched cohort study. J Infect 2016;73:346-57.
Smit J. Community-acquired Staphylococcus aureus
bacteremia: Studies of risk and prognosis with special attention to diabetes mellitus and chronic heart failure. Dan Med J 2017;64. pii: B5379.
Smit J, Thomsen RW, Schønheyder HC, Nielsen H, Frøslev T, Søgaard M. Outcome of community-acquired Staphylococcus aureus
bacteraemia in patients with diabetes: A historical population-based cohort study. PLoS One 2016;11:e0153766.
Azari AA, Barney NP. Conjunctivitis: A systematic review of diagnosis and treatment. JAMA 2013;310:1721-9.
O'Callaghan RJ. The pathogenesis of Staphylococcus aureus
eye infections. Pathogens 2018;7. pii: E9.
Chauhan H, Patil S, Hajare A, Krishnaprasad K, Bhargava A. Necrotizing fasciitis of hand by methicillin resistant Staphylococcus aureus
(MRSA) – A sinister. J Clin Diagn Res 2015;9:DD01-2.
Non L, Kosmin A. Fulminant necrotising fasciitis by community-acquired methicillin-resistant Staphylococcus aureus
. BMJ Case Rep 2015;2015. pii: bcr2014206848.
Cranendonk DR, Lavrijsen AP, Prins JM, Wiersinga WJ. Cellulitis: Current insights into pathophysiology and clinical management. Neth J Med 2017;75:366-78.
Soni P, Parihar RS, Soni LK. Opportunistic microorganisms in oral cavity according to treatment status in head and neck cancer patients. J Clin Diagn Res 2017;11:DC14-7.
[Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5], [Figure 6], [Figure 7], [Figure 8], [Figure 9]